QQQ   313.23 (-1.62%)
AAPL   123.41 (-1.37%)
MSFT   229.79 (-1.74%)
FB   256.95 (-0.79%)
GOOGL   2,032.23 (-1.56%)
TSLA   680.46 (-0.87%)
AMZN   3,040.12 (-1.76%)
NVDA   519.55 (-3.11%)
BABA   235.54 (+0.48%)
CGC   33.96 (-3.66%)
GE   13.37 (+3.00%)
MU   91.52 (+0.47%)
NIO   42.96 (-0.76%)
AMD   82.60 (-1.82%)
T   28.37 (+0.53%)
F   12.20 (-2.79%)
ACB   10.72 (-2.81%)
DIS   193.99 (+0.03%)
BA   229.24 (+2.73%)
NFLX   527.61 (-3.69%)
PFE   33.61 (+0.30%)
QQQ   313.23 (-1.62%)
AAPL   123.41 (-1.37%)
MSFT   229.79 (-1.74%)
FB   256.95 (-0.79%)
GOOGL   2,032.23 (-1.56%)
TSLA   680.46 (-0.87%)
AMZN   3,040.12 (-1.76%)
NVDA   519.55 (-3.11%)
BABA   235.54 (+0.48%)
CGC   33.96 (-3.66%)
GE   13.37 (+3.00%)
MU   91.52 (+0.47%)
NIO   42.96 (-0.76%)
AMD   82.60 (-1.82%)
T   28.37 (+0.53%)
F   12.20 (-2.79%)
ACB   10.72 (-2.81%)
DIS   193.99 (+0.03%)
BA   229.24 (+2.73%)
NFLX   527.61 (-3.69%)
PFE   33.61 (+0.30%)
QQQ   313.23 (-1.62%)
AAPL   123.41 (-1.37%)
MSFT   229.79 (-1.74%)
FB   256.95 (-0.79%)
GOOGL   2,032.23 (-1.56%)
TSLA   680.46 (-0.87%)
AMZN   3,040.12 (-1.76%)
NVDA   519.55 (-3.11%)
BABA   235.54 (+0.48%)
CGC   33.96 (-3.66%)
GE   13.37 (+3.00%)
MU   91.52 (+0.47%)
NIO   42.96 (-0.76%)
AMD   82.60 (-1.82%)
T   28.37 (+0.53%)
F   12.20 (-2.79%)
ACB   10.72 (-2.81%)
DIS   193.99 (+0.03%)
BA   229.24 (+2.73%)
NFLX   527.61 (-3.69%)
PFE   33.61 (+0.30%)
QQQ   313.23 (-1.62%)
AAPL   123.41 (-1.37%)
MSFT   229.79 (-1.74%)
FB   256.95 (-0.79%)
GOOGL   2,032.23 (-1.56%)
TSLA   680.46 (-0.87%)
AMZN   3,040.12 (-1.76%)
NVDA   519.55 (-3.11%)
BABA   235.54 (+0.48%)
CGC   33.96 (-3.66%)
GE   13.37 (+3.00%)
MU   91.52 (+0.47%)
NIO   42.96 (-0.76%)
AMD   82.60 (-1.82%)
T   28.37 (+0.53%)
F   12.20 (-2.79%)
ACB   10.72 (-2.81%)
DIS   193.99 (+0.03%)
BA   229.24 (+2.73%)
NFLX   527.61 (-3.69%)
PFE   33.61 (+0.30%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Precision BioSciencesDBV TechnologiesAdaptimmune TherapeuticsRubius TherapeuticsVaxart
SymbolNASDAQ:DTILNASDAQ:DBVTNASDAQ:ADAPNASDAQ:RUBYNASDAQ:VXRT
Price Information
Current Price$11.55$5.33$5.35$9.60$6.78
52 Week RangeBuyHoldHoldHoldBuy
MarketRank™
Overall Score1.51.21.61.71.3
Analysis Score3.43.13.23.23.5
Community Score2.82.42.42.32.5
Dividend Score0.00.00.00.00.0
Ownership Score0.80.02.52.50.0
Earnings & Valuation Score0.60.60.00.60.6
Analyst Ratings
Consensus RecommendationBuyHoldHoldHoldBuy
Consensus Price Target$20.00$7.07$15.50$13.25$19.50
% Upside from Price Target73.16% upside32.67% upside189.72% upside38.02% upside187.61% upside
Trade Information
Market Cap$645.50 million$578.95 million$840.45 million$797.21 million$781.61 million
Beta2.082.912.42.37-0.11
Average Volume1,211,3101,017,0571,180,271717,77619,323,588
Sales & Book Value
Annual Revenue$22.24 million$14.75 million$1.12 millionN/A$9.86 million
Price / Sales27.2539.70739.35N/A75.27
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.72 per share$2.11 per share$1.18 per share$3.44 per share$0.27 per share
Price / Book4.252.534.53N/A25.11
Profitability
Net Income$-92,880,000.00$-172,020,000.00$-137,160,000.00$-163,460,000.00$-18,650,000.00
EPS($1.91)($2.33)($1.32)($2.08)($0.86)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-484.81%N/A-3,858.14%N/A-281.50%
Return on Equity (ROE)-105.74%N/A-44.94%-77.33%-84.90%
Return on Assets (ROA)-53.08%N/A-33.70%-49.05%-44.67%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.08%N/A0.43%N/A
Current Ratio2.92%4.28%12.23%7.15%3.98%
Quick Ratio2.92%4.22%12.23%7.15%3.98%
Ownership Information
Institutional Ownership Percentage48.57%32.49%99.79%93.74%17.90%
Insider Ownership Percentage14.30%15.31%18.89%58.40%7.30%
Miscellaneous
Employees22331142019730
Shares Outstanding52.48 million109.86 million154.78 million81.18 million109.47 million
Next Earnings Date3/9/2021 (Estimated)3/4/2021 (Confirmed)5/13/2021 (Estimated)5/10/2021 (Estimated)5/11/2021 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.